{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:04:38Z","timestamp":1791122678913,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.neuropharm.2009.08.020","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T09:41:08Z","timestamp":1253094068000},"page":"608-618","source":"Crossref","is-referenced-by-count":170,"title":["The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety"],"prefix":"10.1016","volume":"57","author":[{"given":"D.J.","family":"Heal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2009.08.020_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneumeth.2006.12.019","article-title":"Reprint of \u201cproblems with spontaneously hypertensive rats (SHR) as a model of attention-deficit\/hyperactivity disorder (AD\/HD)\u201d","volume":"166","author":"Alsop","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-9081-1-2","article-title":"Methylphenidate improves prefrontal cortical cognitive function through \u03b12-adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder","volume":"1","author":"Arnsten","year":"2005","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/cap.2006.0098","article-title":"\u03b12-Adrenergic receptor agonists for the treatment of attention-deficit\/hyperactivity disorder: emerging concepts from new data","volume":"17","author":"Arnsten","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00004583-199007000-00007","article-title":"The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study","volume":"29","author":"Barkley","year":"1990","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.2005-0617","article-title":"Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit\/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study","volume":"116","author":"Biederman","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clinthera.2006.02.008","article-title":"A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit\/hyperactivity disorder","volume":"28","author":"Biederman","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2007.04.015","article-title":"Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study","volume":"62","author":"Biederman","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0149-2918(07)80083-X","article-title":"Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit\/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study","volume":"29","author":"Biederman","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib7","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2006-3695","article-title":"A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"121","author":"Biederman","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1176\/appi.ajp.2007.07091486","article-title":"Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study","volume":"165","author":"Biederman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0024-3205(93)90194-8","article-title":"Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes","volume":"52","author":"Bolden-Watson","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.94.3.577","article-title":"Behaviour of children receiving benzedrine","volume":"94","author":"Bradley","year":"1937","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-4328(99)00156-4","article-title":"Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: acquisition and performance of the DRL-60s test","volume":"109","author":"Bull","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0304-3940(91)90869-U","article-title":"Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis","volume":"122","author":"Butcher","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neubiorev.2003.08.008","article-title":"Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdialysis study","volume":"27","author":"Carboni","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archpsyc.1996.01830070053009","article-title":"Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder","volume":"53","author":"Castellanos","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib18","unstructured":"Cheetham, S.C., Kulkarni, R.S., Rowley, H.L., Heal, D.J., 2007. The SH rat model of ADHD has profoundly different catecholaminergic responses to amphetamine's enantiomer compared with SDs. SfN on-line, Abstract 386.7."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib19","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/00004583-199610000-00018","article-title":"Bupropion hydrochloride in attention deficit disorder with hyperactivity","volume":"35","author":"Conners","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib20","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1097\/00001756-200111160-00032","article-title":"Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats","volume":"12","author":"de Saint Hilaire","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib21","unstructured":"Dexamphetamine sulphate US Product Label. http:\/\/dalymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?id=6523."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archpsyc.1989.01810030011002","article-title":"Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings","volume":"46","author":"Donnelly","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0893-133X(02)00303-2","article-title":"Comparisons of behavioural and neurochemical characteristics between WKY, WKHA, and Wistar rat strains","volume":"27","author":"Drolet","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/mrdd.10079","article-title":"A review of the biological bases of ADHD: what have we learned from imaging studies?","volume":"9","author":"Durston","year":"2003","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2006.07.035","article-title":"Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain","volume":"52","author":"Easton","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.100.4.662","article-title":"Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial","volume":"100","author":"Efron","year":"1997","journal-title":"Pediatrics"},{"issue":"340","key":"10.1016\/j.neuropharm.2009.08.020_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM199903113401007","article-title":"Treatment of attention-deficit hyperactivity disorder","volume":"11","author":"Elia","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib28","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1523\/JNEUROSCI.18-15-05901.1998","article-title":"DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [Fluorine-18] fluorodopa positron emission tomographic study","volume":"18","author":"Ernst","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/1087054706292196","article-title":"Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with ADHD","volume":"11","author":"Faraone","year":"2007","journal-title":"J.\u00a0Atten. Disord."},{"issue":"Suppl. 11","key":"10.1016\/j.neuropharm.2009.08.020_bib30","first-page":"9","article-title":"Does stimulant treatment lead to substance use disorders?","volume":"64","author":"Faraone","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ntt.2007.07.001","article-title":"Baseline behavior, but not sensitivity to stimulant drugs, differs among spontaneously hypertensive, Wistar\u2013Kyoto, and Sprague\u2013Dawley rat strains","volume":"29","author":"Ferguson","year":"2007","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jnr.10196","article-title":"Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression","volume":"68","author":"Ferraro","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib33","unstructured":"Findling, R.L., Childress, A.C., Krishnan, S., McGough, J.J., 2007. Long-term efficacy and safety of lisdexamphetamine in school-age children with attention-deficit\/hyperactivity disorder. American Psychiatric Assoc. In: 160th Ann. Meeting poster, San Diego."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(96)12963-3","article-title":"Amphetamine releases dopamine from synaptic vesicles by dual mechanisms","volume":"215","author":"Floor","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib35","unstructured":"Focalin\u00ae US Product Label. 2007. http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?id=3914."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2004.10.001","article-title":"Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder","volume":"5","author":"Fone","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuroimage.2008.07.020","article-title":"Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine","volume":"43","author":"Fowler","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2007.09.008","article-title":"Impulsive choice in a rodent model of attention-deficit\/hyperactivity disorder","volume":"187","author":"Fox","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib39","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/sj.bjp.0705396","article-title":"Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamus","volume":"139","author":"G\u00e9ranton","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archpsyc.1985.01790330017002","article-title":"Hyperactive boys almost grown up. I. Psychiatric status","volume":"42","author":"Gittelman","year":"1985","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.chi.0000205709.63571.c9","article-title":"A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"45","author":"Greenhill","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib42","unstructured":"Groenewoud, P.J., 2006. Abuse Resistant Pharmaceutical Dosage and Method of Making Same. United States Patent Application no. 20060051298."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2006.09.001","article-title":"Response acquisition with delayed reinforcement in a rodent model of attention-deficit\/hyperactivity disorder (ADHD)","volume":"175","author":"Hand","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib47","first-page":"325P","article-title":"Efflux of [3H]dopamine from superfused rat striatal slices: predictive value for detecting stimulant drugs of abuse","volume":"117","author":"Heal","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bjp.0702067","article-title":"A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents","volume":"125","author":"Heal","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pbb.2008.03.016","article-title":"New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD","volume":"90","author":"Heal","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00023210-200620090-00002","article-title":"Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system","volume":"20","author":"Heal","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0376-8716(02)00053-4","article-title":"Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users","volume":"67","author":"Heil","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2006.11.048","article-title":"Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex","volume":"558","author":"Horner","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0278-5846(82)80179-6","article-title":"Citalopram \u2013 pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity","volume":"6","author":"Hyttel","year":"1982","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2008.01.008","article-title":"Abuse liability assessment of atomoxetine in a drug-abusing population","volume":"95","author":"Jasinski","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/0269881108093841","article-title":"Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers","author":"Jasinski","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib52","doi-asserted-by":"crossref","DOI":"10.1177\/0269881109103113","article-title":"Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse","author":"Jasinski","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib54","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1176\/appi.ajp.162.9.1628","article-title":"Cost-effectiveness of ADHD treatments: findings from the Multimodal Treatment Study of children with ADHD","volume":"162","author":"Jensen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1037\/0735-7044.122.2.340","article-title":"Advancing the spontaneous hypertensive rat model of attention deficit\/hyperactivity disorder","volume":"122","author":"Kantak","year":"2008","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib56","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/BF02849870","article-title":"Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multi-center, randomized prospective study","volume":"22","author":"Kemner","year":"2005","journal-title":"Adv. Ther."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0163-1047(79)91801-6","article-title":"Open-field behaviour of spontaneously hypertensive rats","volume":"27","author":"Knardahl","year":"1979","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib58","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/0044011-200828120-00002","article-title":"Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers","volume":"28","author":"Krishnan","year":"2008","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib59","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1471-4159.1997.68052032.x","article-title":"Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine","volume":"68","author":"Kuczenski","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/10401230109148958","article-title":"Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults","volume":"13","author":"Kuperman","year":"2001","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib61","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1037\/1064-1297.14.2.136","article-title":"Discriminative-stimulus, self-reported, performance and cardiovascular effects of atomoxetine in methylphenidate-trained humans","volume":"14","author":"Lile","year":"2006","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11126-005-2979-0","article-title":"Review and comparison of the long acting methylphenidate preparations","volume":"76","author":"Liu","year":"2005","journal-title":"Psychiatry Quart."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib63","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1742-7843.2008.00230.x","article-title":"Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat","volume":"102","author":"Liu","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro","volume":"319","author":"Madras","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib65","first-page":"1896","article-title":"Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study","volume":"159","author":"Michelson","year":"2002","journal-title":"Am. J. Psychother."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib66","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0006-2952(80)90429-3","article-title":"In vivo monoamine oxidase inhibition by d-amphetamine","volume":"29","author":"Miller","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib67","first-page":"1477","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib68","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0031-9384(94)90327-1","article-title":"Different effects of amphetamine on reinforced variations versus repetitions on spontaneously hypertensive rats (SHR)","volume":"56","author":"Mook","year":"1994","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib69","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder","volume":"56","author":"MTA Cooperative Group","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib70","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1542\/peds.113.4.754","article-title":"National Institute of Mental Health Multimodal Treatment Study of ADHD follow up: 24-month outcomes of treatment strategies for attention-deficit\/hyperactivity disorder","volume":"113","author":"MTA Cooperative Group","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00004703-199806000-00006","article-title":"Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children","volume":"19","author":"Musser","year":"1998","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib72","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1176\/appi.ajp.2007.05091676","article-title":"Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response","volume":"165","author":"Newcorn","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbr.2008.03.012","article-title":"Performance of spontaneously hypertensive rats in a peak-interval procedure with gaps","volume":"191","author":"Ordu\u00f1a","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib74","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib75","unstructured":"Pennick, M., 2009. Hydrolytic conversion of lisdexamfetamine dimesylate to the active moiety, d-amphetamine. Soc. Biol. Psychiatr. In: 64th Ann. Sci. Conv. Meeting, May 14\u201316th, Vancouver, BC, Canada."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib76","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1056-4993(18)30109-3","article-title":"Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit\/hyperactivity disorder","volume":"9","author":"Popper","year":"2000","journal-title":"Child Adolesc. Psychiatry Clin. N. Am."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib77","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00004583-199407000-00015","article-title":"Attention deficit disorder and methylphenidate rates, clinical effectiveness and response prediction in 76 children","volume":"33","author":"Rapport","year":"1994","journal-title":"J. Am. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib78","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(84)90403-5","article-title":"Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake","volume":"104","author":"Richelson","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib79","doi-asserted-by":"crossref","first-page":"E847","DOI":"10.1208\/aapsj070481","article-title":"Role of monoamine transporters in mediating psychostimulant effects","volume":"7","author":"Riddle","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2007.05.044","article-title":"Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2","volume":"571","author":"Riddle","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib81","unstructured":"Ritalin\u00ae US Product Label. 2007. http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?id=4249."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib82","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.physbeh.2008.02.016","article-title":"The working memory capabilities of the spontaneously hypertensive rat","volume":"94","author":"Robertson","year":"2008","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib83","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/0006-2952(85)90201-1","article-title":"Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, n-methylamphetamine and deprenyl","volume":"34","author":"Robinson","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib84","first-page":"293","article-title":"A review of modafinil film-coated tablets for attention-deficit\/hyperactivity disorder in children and adolescents","volume":"3","author":"Rugino","year":"2007","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0149-7634(99)00058-5","article-title":"Behavioural validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit\/hyperactivity disorder (AD\/HD)","volume":"24","author":"Sagvolden","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib86","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0031-9384(93)90323-8","article-title":"Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behaviour compared to four other rats strains","volume":"54","author":"Sagvolden","year":"1993","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib87","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.biopsych.2005.02.002","article-title":"Rodent models of attention-deficit\/hyperactivity disorder","volume":"57","author":"Sagvolden","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1744-9081-4-3","article-title":"l-Amphetamine improves poor sustained attention while d-amphetamine reduces over activity and impulsiveness as well as improves sustained attention in an animal model of attention-deficit\/hyperactivity disorder (ADHD)","volume":"4","author":"Sagvolden","year":"2008","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib89","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1523\/JNEUROSCI.22-19-08705.2002","article-title":"Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors","volume":"22","author":"Sandoval","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib90","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention-deficit\/hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib91","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00023210-200519080-00001","article-title":"Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications","volume":"19","author":"Schubiner","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib92","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00213-002-1288-7","article-title":"Neurochemical and behavioural differences between d-methamphetamine and d-amphetamine in rats","volume":"165","author":"Shoblock","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib93","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00003072-199501000-00014","article-title":"SPECT brain imaging abnormalities in attention deficit hyperactivity disorder","volume":"20","author":"Sieg","year":"1995","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib94","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1742-1241.2007.01519.x","article-title":"Clinical assessment and treatment of ADHD in children","volume":"61","author":"Smoot","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib95","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004583-199604000-00008","article-title":"Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle","volume":"35","author":"Spencer","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib96","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1176\/ajp.155.5.693","article-title":"Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder","volume":"155","author":"Spencer","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib97","first-page":"11S","article-title":"Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African\u2013American children with ADHD","volume":"97","author":"Starr","year":"2005","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib98","first-page":"S89","article-title":"Innovations in attention-deficit\/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments","volume":"10","author":"Stein","year":"2004","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib99","first-page":"S99","article-title":"Attention-deficit\/hyperactivity disorder: medication treatment-dosing and duration of action","volume":"10","author":"Steinhoff","year":"2004","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0896-6273(90)90339-H","article-title":"Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action","author":"Sulzer","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib101","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4088\/JCP.v67n0120","article-title":"Modafinil film-coated tablets in children and adolescents with attention-deficit\/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation","volume":"67","author":"Swanson","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib102","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.neuropharm.2005.11.022","article-title":"Effect of the attention deficit\/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat","volume":"50","author":"Swanson","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib104","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pbb.2006.02.018","article-title":"Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder","volume":"83","author":"van den Bergh","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(91)90299-6","article-title":"Delineation of rat kidney alpha 2A- and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an alpha 2A-selective compound","volume":"202","author":"Uhl\u00e9n","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-3565(25)33390-2","article-title":"Similar dopamine-releasing effects of phencyclidine and non-amphetamine stimulants in striatal slices","volume":"233","author":"Vickroy","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib108","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1176\/appi.ajp.160.11.1909","article-title":"Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD","volume":"160","author":"Volkow","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib107","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archneur.64.11.1575","article-title":"Dopamine in drug abuse and addiction: results of imaging studies and treatment implications","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib106","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib109","unstructured":"Vyvanse\u2122 US Product Label. 2008. http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?id=6072."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib110","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00169306","article-title":"The use of tetrodotoxin for the characterisation of drug-enhanced dopamine release in conscious rats studied by brain dialysis","volume":"336","author":"Westerink","year":"1987","journal-title":"Naunyn-Schmied Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib113","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1087054705281121","article-title":"A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit\/hyperactivity disorder","volume":"9","author":"Wigal","year":"2005","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib111","first-page":"352","article-title":"Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit\/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies","volume":"8","author":"Wigal","year":"2006","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib112","unstructured":"Wigal, S., Kollins, S., Squires, L., Childress, A.C., 2008. Lisdexamfetamine dimesylate demonstrated efficacy throughout the day up to 13 hours in an analog classroom study in children with ADHD. Am. Acad. Child Adolesc. Psychiatr. In: 55th Ann. Meeting, Chicago, Poster 311."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0193-953X(18)30265-X","article-title":"The stimulants","volume":"15","author":"Wilens","year":"1992","journal-title":"Psychiatry Clin. North Am."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib114","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2009.08.020_bib116","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0702859","article-title":"Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by \u03b12-adrenoceptors","volume":"128","author":"Wortley","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib117","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0163-1047(90)90848-Z","article-title":"The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behaviour","volume":"53","author":"Wultz","year":"1990","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.neuropharm.2009.08.020_bib118","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.108.146142","article-title":"Evidence for the involvement of dopamine transporters in behavioural stimulant effects of modafinil","volume":"329","author":"Zolkowska","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809002688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809002688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T05:36:58Z","timestamp":1739338618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390809002688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":118,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0028390809002688"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2009.08.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}